Therapy Compliance of Type-2 Diabetes Mellitus Patients Before and During The Covid-19 Pandemic: A Systematic Review

Medical compliance is a key aspect in the management of multiple-modalities therapies, such as those found in patients with type-2 diabetes mellitus. Aspects such as healthcare accessibility, complications or secondary ailments, lifestyle, socioeconomic status, and academic status can affect a patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Hidtsa Aqila Noor Arasyi, Dimas Luthfi Razantira, Fina Jazilah Rizqiyah, Salsabilla Zahra Prasetya, Defo Aro Ernadiyanto, Budi Utomo
Format: Article
Language:English
Published: Universitas Airlangga 2023-06-01
Series:Journal of Community Medicine and Public Health Research
Online Access:https://e-journal.unair.ac.id/JCMPHR/article/view/44310
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849220797097312256
author Hidtsa Aqila Noor Arasyi
Dimas Luthfi Razantira
Fina Jazilah Rizqiyah
Salsabilla Zahra Prasetya
Defo Aro Ernadiyanto
Budi Utomo
author_facet Hidtsa Aqila Noor Arasyi
Dimas Luthfi Razantira
Fina Jazilah Rizqiyah
Salsabilla Zahra Prasetya
Defo Aro Ernadiyanto
Budi Utomo
author_sort Hidtsa Aqila Noor Arasyi
collection DOAJ
description Medical compliance is a key aspect in the management of multiple-modalities therapies, such as those found in patients with type-2 diabetes mellitus. Aspects such as healthcare accessibility, complications or secondary ailments, lifestyle, socioeconomic status, and academic status can affect a patient's compliance, thus their therapeutic outcomes. The Covid-19 pandemic brought various observable shifts toward these aspects which raises the need for further evaluation regarding type-2 diabetes mellitus therapy compliance during the Covid-19 pandemic. This study is a systematic review that uses secondary data gathered from articles published in Pubmed, ScienceDirect, and Google Scholar with publication dates ranging from January 2018 until October 2021. Using the PRISMA algorithm and JBI critical appraisal questionnaire, we selected 10 controlled studies that discussed therapy compliance of Type-2 Diabetes Mellitus patients before the Covid-19 pandemic and 7 studies that discussed therapy compliance of Type-2 Diabetes Mellitus during the Covid-19 pandemic. There was a notable difference between the therapy compliance profile of Type-2 Diabetes Mellitus patients before and during the Covid-19 pandemic. Pharmacotherapy compliance during the Covid-19 pandemic showed a moderate-high trend whereas the trend before the Covid-19 pandemic was moderate-low. Compliance of physical activity and diet modification related to Type-2 Diabetes Mellitus respectively showed a moderate-high and moderate-low trend during the Covid-19 pandemic, whereas the trend before Covid-19 pandemic was low. A notable shift was found between the therapy compliance profile of Type-2 Diabetes Mellitus patients  before and during the Covid-19 pandemic. Further meta-analysis study is required to measure the significance of this shift as well as their correlations. Additional studies are also required to isolate the factors that may contribute to this shift.
format Article
id doaj-art-2ddfdcc7e6cb43aeae9f3efd9da657a8
institution Kabale University
issn 2723-035X
language English
publishDate 2023-06-01
publisher Universitas Airlangga
record_format Article
series Journal of Community Medicine and Public Health Research
spelling doaj-art-2ddfdcc7e6cb43aeae9f3efd9da657a82024-12-05T07:59:09ZengUniversitas AirlanggaJournal of Community Medicine and Public Health Research2723-035X2023-06-0141738310.20473/jcmphr.v4i1.4431042392Therapy Compliance of Type-2 Diabetes Mellitus Patients Before and During The Covid-19 Pandemic: A Systematic ReviewHidtsa Aqila Noor Arasyi0Dimas Luthfi Razantira1Fina Jazilah Rizqiyah2Salsabilla Zahra Prasetya3Defo Aro Ernadiyanto4Budi Utomo5Medical Student, Faculty of Medicine, Universitas Airlangga, SurabayaMedical Student, Faculty of Medicine, Universitas Airlangga, SurabayaMedical Student, Faculty of Medicine, Universitas Airlangga, SurabayaMedical Student, Faculty of Medicine, Universitas Airlangga, SurabayaMedical Student, Faculty of Medicine, Universitas Airlangga, SurabayaDepartment of Public Health-Preventive Medicine, Faculty of Medicine, Universitas Airlangga, IndonesiaMedical compliance is a key aspect in the management of multiple-modalities therapies, such as those found in patients with type-2 diabetes mellitus. Aspects such as healthcare accessibility, complications or secondary ailments, lifestyle, socioeconomic status, and academic status can affect a patient's compliance, thus their therapeutic outcomes. The Covid-19 pandemic brought various observable shifts toward these aspects which raises the need for further evaluation regarding type-2 diabetes mellitus therapy compliance during the Covid-19 pandemic. This study is a systematic review that uses secondary data gathered from articles published in Pubmed, ScienceDirect, and Google Scholar with publication dates ranging from January 2018 until October 2021. Using the PRISMA algorithm and JBI critical appraisal questionnaire, we selected 10 controlled studies that discussed therapy compliance of Type-2 Diabetes Mellitus patients before the Covid-19 pandemic and 7 studies that discussed therapy compliance of Type-2 Diabetes Mellitus during the Covid-19 pandemic. There was a notable difference between the therapy compliance profile of Type-2 Diabetes Mellitus patients before and during the Covid-19 pandemic. Pharmacotherapy compliance during the Covid-19 pandemic showed a moderate-high trend whereas the trend before the Covid-19 pandemic was moderate-low. Compliance of physical activity and diet modification related to Type-2 Diabetes Mellitus respectively showed a moderate-high and moderate-low trend during the Covid-19 pandemic, whereas the trend before Covid-19 pandemic was low. A notable shift was found between the therapy compliance profile of Type-2 Diabetes Mellitus patients  before and during the Covid-19 pandemic. Further meta-analysis study is required to measure the significance of this shift as well as their correlations. Additional studies are also required to isolate the factors that may contribute to this shift.https://e-journal.unair.ac.id/JCMPHR/article/view/44310
spellingShingle Hidtsa Aqila Noor Arasyi
Dimas Luthfi Razantira
Fina Jazilah Rizqiyah
Salsabilla Zahra Prasetya
Defo Aro Ernadiyanto
Budi Utomo
Therapy Compliance of Type-2 Diabetes Mellitus Patients Before and During The Covid-19 Pandemic: A Systematic Review
Journal of Community Medicine and Public Health Research
title Therapy Compliance of Type-2 Diabetes Mellitus Patients Before and During The Covid-19 Pandemic: A Systematic Review
title_full Therapy Compliance of Type-2 Diabetes Mellitus Patients Before and During The Covid-19 Pandemic: A Systematic Review
title_fullStr Therapy Compliance of Type-2 Diabetes Mellitus Patients Before and During The Covid-19 Pandemic: A Systematic Review
title_full_unstemmed Therapy Compliance of Type-2 Diabetes Mellitus Patients Before and During The Covid-19 Pandemic: A Systematic Review
title_short Therapy Compliance of Type-2 Diabetes Mellitus Patients Before and During The Covid-19 Pandemic: A Systematic Review
title_sort therapy compliance of type 2 diabetes mellitus patients before and during the covid 19 pandemic a systematic review
url https://e-journal.unair.ac.id/JCMPHR/article/view/44310
work_keys_str_mv AT hidtsaaqilanoorarasyi therapycomplianceoftype2diabetesmellituspatientsbeforeandduringthecovid19pandemicasystematicreview
AT dimasluthfirazantira therapycomplianceoftype2diabetesmellituspatientsbeforeandduringthecovid19pandemicasystematicreview
AT finajazilahrizqiyah therapycomplianceoftype2diabetesmellituspatientsbeforeandduringthecovid19pandemicasystematicreview
AT salsabillazahraprasetya therapycomplianceoftype2diabetesmellituspatientsbeforeandduringthecovid19pandemicasystematicreview
AT defoaroernadiyanto therapycomplianceoftype2diabetesmellituspatientsbeforeandduringthecovid19pandemicasystematicreview
AT budiutomo therapycomplianceoftype2diabetesmellituspatientsbeforeandduringthecovid19pandemicasystematicreview